MENU
+Compare
GDTC
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$1.54
Change
+$0.03 (+1.99%)
Capitalization
18.07M

GDTC CytoMed Therapeutics Limited Forecast, Technical & Fundamental Analysis

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers... Show more

GDTC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for GDTC with price predictions
Dec 24, 2025

GDTC sees MACD Histogram crosses below signal line

GDTC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 09, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 30 instances where the indicator turned negative. In of the 30 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GDTC as a result. In of 54 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GDTC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GDTC entered a downward trend on December 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GDTC's RSI Indicator exited the oversold zone, of 11 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 40 cases where GDTC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GDTC advanced for three days, in of 109 cases, the price rose further within the following month. The odds of a continued upward trend are .

GDTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.248) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (101.010) is also within normal values, averaging (311.015).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GDTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GDTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
GDTC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

GDTC is expected to report earnings to fall 78.95% to -3 cents per share on May 04

CytoMed Therapeutics Limited GDTC Stock Earnings Reports
Q4'25
Est.
$-0.04
Q2'25
Missed
by $0.15
Q4'24
Missed
by $0.08
Q3'24
Est.
$-0.04
Q2'24
Beat
by $0.01
The last earnings report on October 02 showed earnings per share of -18 cents, missing the estimate of -3 cents. With 5.94K shares outstanding, the current market capitalization sits at 18.07M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Commonwealth Lane
Phone
+65 62507738
Employees
28
Web
https://w2.cytomed.sg
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHRB63.590.48
+0.76%
Burke & Herbert Financial Services Corp
MSTR158.710.83
+0.53%
Strategy Inc
DSP11.930.04
+0.34%
Viant Technology
MUR31.450.09
+0.29%
Murphy Oil Corp
CETX2.43-0.04
-1.62%
Cemtrex Inc

GDTC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GDTC has been loosely correlated with CYCN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GDTC jumps, then CYCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
+1.65%
CYCN - GDTC
35%
Loosely correlated
-3.50%
CVKD - GDTC
29%
Poorly correlated
+1.80%
QSI - GDTC
28%
Poorly correlated
+6.50%
ADIL - GDTC
27%
Poorly correlated
-2.92%
RPRX - GDTC
27%
Poorly correlated
-0.36%
More